MedTrace Logo

Brazilian Prospective Hodgkin Lymphoma Registry

NCT02589548 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2022-05-17

No results posted yet for this study

Summary

The study is a prospective registry of Hodgkin Lymphoma (HL) patients in Brazil.

The purpose of the study is to gather clinical, epidemiologic and outcomes data on the treatment of HL, on the basis of records collected by key Brazilian institutions, through a centralized web-based registry of clinical data verified by central board of hematopathologists.

Conditions

Sponsors & Collaborators

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Principal Investigators

  • Nelson Spector, MD · UFRJ

  • Irene Biasoli · UFRJ

Eligibility

Min Age
12 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02589548 on ClinicalTrials.gov